INTRODUCTION
The stimulation by insulin of glucose transport activity in target tissues is mainly due to the translocation of the GLUT4 isoform from an intracellular vesicle pool to the plasma membrane [1, 2] . The GLUT4 translocation process has been demonstrated in both adipose [3] and muscle [4] target tissues but also in the insulin-responsive cell line, 3T3-LI [5] . The stimulation of GLUT4 translocation has been shown to be due to increased exocytosis of GLUT4 vesicles to the cell surface of both rat adipose cells [6] and 3T3-LI cells [7] , but the mechanism of signalling to the vesicle exocytosis process has not been studied in detail. A plausible candidate as a signalling intermediate between the insulin receptor and the GLUT4-vesicle translocation process is the enzyme Ptdlns 3-kinase. The yeast homologue (VPS34) is known to be involved in vesicle budding and sorting processes [8] . Furthermore, the p1 10 catalytic subunit of Ptdlns 3-kinase is now known to associate with insulin receptor substrate 1 (IRS1) through its associated a-p85 subunit. Two SH2 domains in a-p85 associate with a repeat YMXM motif in IRS I following tyrosine phosphorylation by the insulinreceptor tyrosine kinase activity [9] [10] [11] [12] [13] .
Evidence that suggests that IRS1-coupled Ptdlns 3-kinase activity may be important in stimulation of glucose transport has been obtained in Chinese hamster ovary (CHO) cells transfected with the insulin receptor plus an a-p85 construct in which the pl10-binding domain is deleted [13] . The presence of this construct prevents normal activation of IRS 1-precipitatable Ptdlns 3-kinase activity and also prevents insulin stimulation of on transport is associated with a reduction in the cell-surface, but not the total cellular, levels of both GLUT1 and GLUT4 glucose transporter isoforms that are accessible to the cell-impermeant photolabel, ATB-BMPA. These photolabelling results suggest that the glucose transporter translocation process is dependent upon Ptdlns 3-kinase activity. The stimulatory effect ofguanosine 5'-[y-thio]triphosphate (GTPyS) on glucose transport activity in permeabilized cells is only partially blocked by concentrations of wortmannin that completely inhibit the stimulatory effect of insulin. The residual stimulatory effect of GTPyS that occurs in the presence of wortmannin suggests that at least part of the GTPyS effect is mediated at a signalling site that is downstream of the site at which wortmannin inhibits the insulin stimulation of Ptdlns 3-kinase and glucose transport activities.
glucose transport. This effect on transport has been attributed to a decreased GLUT1 translocation to the cell surface of the CHO cells, as detected using the bis-mannose photolabel, 2-N-4-(1-azi-2,2,2-trifluoroethyl)benzoyl-1,3-bis(D-mannos-4-yloxy)-2-propylamine (ATB-BMPA).
An important tool for investigation ofthe possible involvement of Ptdlns 3-kinase in insulin stimulatory processes would be a potent and specific inhibitor of this enzyme. Wortmannin appears to be such a reagent, inhibiting Ptdlns 3-kinase in the nanomolar concentration range but activities including phospholipase D, protein kinase C, cyclic GMP-dependent-, cyclic AMP-dependent-and calmodulin-dependent protein kinases, platelet-derived growth factor-receptor tyrosine kinase and myosin lightchain kinase (MLCK) in the micromolar concentration range [14] . Recently, Kanai et al. [15] have shown that wortmannin inhibits both Ptdlns 3-kinase activity and GLUT4 translocation in CHO cells expressing the insulin receptor and a GLUT4 construct tagged by the myc epitope.
3T3-L1 cells are much more acutely sensitive to insulin than CHO cells so, in order to further demonstrate that the wortmannin inhibitory effect on glucose transport is associated with impairment of the glucose-transporter translocation process, we have studied GLUT1 and GLUT4 translocation in 3T3-LI cells using the ATB-BMPA photolabelling technique [5, 16] . The demonstration that, in a highly insulin-responsive cell line, GLUT1 and GLUT4 translocation is sensitive to wortmannin in a manner that correlates with inhibition of Ptdlns 3-kinase activity adds to the evidence for PtdIns 3-kinase involvement in insulin signalling to the glucose transporter vesicle translocation Glucose transport activity Differentiated adipocytes in 35-mm-diam. dishes were maintained at 37°C either in the presence or absence of 100 nM porcine monocomponent insulin for 30 min. The cells were then incubated with 50 #uM 2-deoxy-D-[2,6-3H]glucose in 1 ml of KRH buffer at 37°C for 5 min. Cells were then rapidly washed three times in KRH buffer at 0-4 0C, and the radioactivity was extracted into 1 ml of 0.1 M NaOH. For experiments in which 3T3-L1 cells were permeabilized, a modification of the method of Robinson et al. [19] was used. 3T3-L1 cells were washed three times with IC buffer (5 mM NaCl, 5 mM EGTA, 5 mM MgCI2,6H20, 20 mM Hepes, 140 mM potassium glutamate, pH 7.2) instead of KRH buffer and incubated for 5 min in 1 ml of IC buffer containing 0.8 i.u. of streptolysin 0 to permeabilize the plasma membranes. The cells were then washed a further three times with IC buffer and incubated in the presence or absence of insulin or GTPyS in IC buffer containing 3 mM sodium pyruvate and 10 mM ATP. The cells were then incubated for 5 min with 50,M 2-deoxy-D-glucose (0.3 ,uCi of 2-deoxy-D-[2,6-3H]glucose) and 0.06 ,uCi [U-14C]sucrose, which was used to correct the tritium counts for non-specific diffusion of the label into the cells. Cells were then rapidly washed once in IC buffer at 0-4°C, and the radioactivity extracted into 1 ml of 0.1 M NaOH.
ATB-BMPA labelling
Cells in 35-mm-diam. dishes were maintained at 37°C in the absence or presence of 100 nM insulin for 30 min. The dishes were washed in KRH buffer and were irradiated for 1 min in a Rayonet photochemical reactor in the presence of 100 ,uCi of ATB-[2-3H]BMPA in 250 ,ul of KRH buffer at 18 'C. To measure labelling of the total cellular transporter pool, cells were permeabilized by treatment with 0.025 % (w/v) digitonin for 8 min at 18 'C in the presence of 100 ,uCi ATB-[2-3H]BMPA [20] . The irradiated cells were washed four times in KRH buffer and solubilized in 1.5 ml of detergent buffer containing 2 % Thesit, 5 mM sodium phosphate and 5 mM EDTA, pH 7.2, and the proteinase inhibitors antipain, aprotinin, pepstatin and leupeptin each at 1 ,ug/ml. After centrifugation at 20000 g for 20 min, the detergent-solubilized samples were subjected to sequential immunoprecipitation with 30 Iel of Protein A-Sepharose coupled with 100 #1 of anti-GLUT 1 or 50 ,ul of anti-GLUT4 serum. The antisera were raised against peptides corresponding in sequence to the GLUTI and GLUT4 C-terminal segments [20] . After incubation for 2 h at 0-4 'C, the immunoprecipitates were washed three times with 1.0 %, and then once in 0.1 %, Thesit detergent buffer. Labelled glucose transporters were then released from the antibody complexes with 10 % (w/v) SDS/6 M urea/10 % (v/v) mercaptoethanol and subjected to electrophoresis on 10 % (w/v) acrylamide gels. The radioactivity on the gel was extracted from the gel slices and estimated by liquid-scintillation counting [20] .
RESULTS

Effects of wortmannin on Ptdins 3-kinase activity
We have examined the effects of wortmannin on Ptdlns 3-kinase activity in both a-p85 and IRSI immunoprecipitates (Table 1) to determine whether wortmannin alters the coupling of Ptdlns 3-kinase to IRS1. Wortmannin inhibits oc-p85-and IRS1-precipitated Ptdlns 3-kinase activity to an equal extent, supporting the suggestion [14] that wortmannin interacts with the 110 kDa Table 1 Effect of wortmannin on IRS1-and a-p85-precipitated Ptdins 3-kinase activity 3T3-L1 cells were incubated in the absence or presence of 100 nM insulin, solubilized in C12E, detergent buffer and then the Ptdlns 3-kinase activity was precipitated using either an aX-p85 or an IRS1 monoclonal antibody preabsorbed with Protein G-Sepharose. The Ptdlns 3-kinase activity in the immunoprecipitates was determined either in the absence or presence of 1 ,uM wortmannin. Results are expressed as a percentage of the activity (mean+ S.E.M., n = 3) obtained from the insulin-treated cells. subunit of Ptdlns 3-kinase. When intact cells are treated with wortmannin, and then Ptdlns 3-kinase is subsequently measured in detergent extracts of washed cells, the activity is higher than that observed when wortmannin is added directly to the Ptdlns 3-kinase assay mixture (Table 1) . This is probably a dilution or inactivation effect, but suggests that the inhibitory effect of wortmannin is partly reversible and is lost following extensive washing of the 3T3-LI cells and immunoprecipitates, which removes or inactivates the inhibitor.
Inhibition of glucose transport activity
The concentrations of wortmannin that are required to inhibit insulin-stimulated Ptdlns 3-kinase activity and glucose transport activity are compared in Figure 1 The impermeant photolabel, ATB-BMPA, has therefore been GLUT1 used to assess whether the observed inhibition of glucose transport activity by wortmannin is associated with reduced translocation of either, or both, of these isoforms. In order to show that wortmannin does not interfere with the glucose transporters directly, we measured the binding of ATB-BMPA in digitonin-permeabilized cells. Figure 3(a) shows that in digitoninpermeabilized cells, the labelling of neither GLUTI nor GLUT4 is altered by wortmannin. Instead, the wortmannin clearly X~reduces the amounts of these isoforms at the cell surface. Figure  3(b) shows the labelling of these isoforms in intact cells that are 0 12 14 fully stimulated by treatment with 100 nM insulin. The levels of labelling observed in the wortmannin-treated samples are reduced 29 A to basal levels. [23, 24] and MAP kinase [25] , these effects may be due to increased transcription [23, 24] and translocation [25] of GLUTI. Evidence against the involvement of MAP kinase activation in the acute insulin stimulation of glucose transport activity has been obtained by comparing the effects of insulin and epidermal growth factor (EGF) on MAP kinase with the corresponding effects on glucose transport stimulation. While EGF and insulin both stimulate MAP kinase phosphorylation [26, 27] , EGF has only a very small effect on glucose transport and GLUT4 translocation in rat adipocytes [28] and on glucose transport in 3T3-L1 cells [26] , attributed to GLUTI translocation [27] . It has been suggested that the reagent ML9, through inhibition of MAP kinase phosphorylation, inhibits glucose transport activation by insulin in 3T3-LI cells [29] . However, ML9 is not specific for MAP kinase kinase and may also inhibit Ptdlns 3-kinase [15] . The insulin-dependent activation of 70K S6 kinase has been shown not to be necessary for glucose transport stimulation [30] .
The possibility that glucose transport activation occurs through coupling of Ptdlns 3-kinase activity to IRS I has recently been explored [13, 15, 17] . Evidence [13, 15, 17] . The attraction of this hypothesis is that Ptdlns 3-kinase is known to be involved in other membrane trafficking events, although it is evident that, at least in the analogous yeast VPS34 system, the Ptdlns 3-kinase operates in conjunction with a protein kinase in controlling membrane trafficking events [8] . It has recently been shown [31] that wortmannin is a potent inhibitor of histamine release from a basophil cell line, and it seems likely that this effect is also mediated by inhibition of Ptdlns 3-kinase activity. Such findings add growing support for the hypothesis that this enzyme will be found to be a key intermediate in many regulated vesicletrafficking processes.
